Anti-MET Antibody Therapies in Non-Small-Cell Lung Cancer: Current Progress and Future Directions
{{output}}
Background/Objectives: Non-small-cell lung cancer (NSCLC) remains a leading cause of cancer mortality globally, though advances in targeted therapies have improved treatment outcomes. The mesenchymal-epithelial transition (MET) gene plays a significant role in... ...
